STOK
Stoke Therapeutics Inc
24.80$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +4,309.1% | +112.7% | +30.2% | -19.8% | +7.2% | -10.8% | +18.9% | +54.1% | |
| – | +5,457.2% | +113.0% | +30.0% | -22.0% | +6.5% | -11.8% | +8.1% | +31.3% | |
| – | +5,765.3% | +111.1% | +29.1% | -49.6% | -21.6% | +68.6% | -33.1% | -34.2% | |
| – | +5,765.3% | +111.1% | +29.1% | -23.5% | +4.5% | -12.3% | +7.7% | +31.2% | |
| – | – | +43.4% | -97.9% | +2,100.0% | +345.5% | -89.1% | +993.8% | +1,029.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +152.0% | +110.7% | +6.5% | +239.4% | -26.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | -33.8% | +74.9% | +174.1% | +78.0% | +237.7% | -3.4% | -38.2% | +55.1% | |
| – | -33.6% | +66.2% | +178.6% | +50.0% | +83.2% | -1.8% | +30.0% | +44.5% | |
| – | -100.0% | – | – | +41.4% | +56.5% | -12.6% | +12.6% | +29.5% | |
| – | +659.6% | -29.9% | +99.1% | +59.5% | -67.9% | +121.3% | +47.4% | +97.7% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +113.6% | +27.5% | -23.9% | -15.1% | -13.7% | +43.5% | +53.9% | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -23.6% | +86.3% | +9.7% | +5.9% | +13.1% | +22.8% | +9.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.